Business
Pfizer raises 2021 COVID-19 vaccine sales forecast to $45.7 billion – ABC News
Drug manufacturer Pfizer is expected to gain $45.7 billion in sales this year as countries stock up on COVID-19 vaccines.
Pfizer has raised its full-year sales forecast for the COVID-19 vaccine it developed with Germany’s BioNTech by 29 per cent to $US33.5 billion ($45.7 billion), as nations stock up on doses for the rest of the year.
Key points:
- There’s been general positive…
Continue Reading
-
General24 hours agoCan recognising the state of Palestine achieve a two-state solution as Israel continues bombing Gaza?
-
Noosa News18 hours agoCelebrate 200 years of steam trains with a ride on the Rattler
-
Business16 hours agoUp 64% in a month! This unique ASX uranium stock is leading the charge amidst sector-wide rally
-
Noosa News18 hours agoSchool holiday patrols target sand and bitumen